Pure Global

Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries - Trial NCT06319859

Access comprehensive clinical trial information for NCT06319859 through Pure Global AI's free database. This Phase 3 trial is sponsored by Cairo University and is currently Not yet recruiting. The study focuses on Pain, Postoperative. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06319859
Phase 3
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06319859
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries
Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries: A Randomized Controlled Clinical Trial.

Study Focus

Pain, Postoperative

Morphine

Interventional

drug

Sponsor & Location

Cairo University

Cairo, Egypt

Timeline & Enrollment

Phase 3

Mar 01, 2024

Oct 01, 2024

50 participants

Primary Outcome

Time to first analgesic requirement

Summary

This study will evaluate the efficacy and safety of intrathecal non-preservative-free
 morphine and its effect on pain in patients undergoing unilateral inguinal hernia surgeries.

ICD-10 Classifications

During surgical operation
During surgical operation
During surgical operation
Pain, unspecified
Postoperative intestinal obstruction

Data Source

ClinicalTrials.gov

NCT06319859

Non-Device Trial